...And as I've stated previously, his ownership here speaks volumes in my honest opinion:
Expecting big things for $RDGL in the coming weeks. FDA has already approved IsoPet™ for use in animals to treat sarcomas and will start being marketed to the veterinary community next month. Disclosure: I own a ton of stock & this is the first penny stock I have ever endorsed.
— George Sharp - Advocate for truth in the OTC (@GeorgeASharp) September 11, 2018
From George: "Expecting big things for $RDGL in the coming weeks. FDA has already approved IsoPet™ for use in animals to treat sarcomas and will start being marketed to the veterinary community next month. Disclosure: I own a ton of stock & this is the first penny stock I have ever endorsed".
For those that dont know who George Sharp is, He is a prolific activist (a bit of a crusader if you will) promoting integrity in the microcap markets.... he RARELY has anything good to say about (any) OTC plays.
I think it is very revealing that that he is touting Vivos as a "real deal" play....And most importantly, he's putting his money where his mouth is.
RDGL: A legitimate cancer play with a low 2 billion A.S. and 551,667,827 outstanding. This is ready to run...and run hard it will.